Wikidata

(Q41743704)

English

Adjuvant chemoendocrine therapy in postmenopausal breast cancer: cyclophosphamide, methotrexate, and fluorouracil dose and schedule may make a difference. International Breast Cancer Study Group

scientific article published on April 1998

In more languages

Statements

title
Adjuvant chemoendocrine therapy in postmenopausal breast cancer: cyclophosphamide, methotrexate, and fluorouracil dose and schedule may make a difference. International Breast Cancer Study Group (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
9552037
retrieved
8 October 2017
author name string
A Goldhirsch
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
9552037
retrieved
8 October 2017
A S Coates
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
9552037
retrieved
8 October 2017
M Colleoni
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
9552037
retrieved
8 October 2017
M Castiglione-Gertsch
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed ID
9552037
retrieved
8 October 2017
R D Gelber
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed ID
9552037
retrieved
8 October 2017
page(s)
1358-1362
1 reference
stated in
Europe PubMed Central
PubMed ID
9552037
retrieved
8 October 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q41743704&oldid=1927257486"